JaLCDOI 10.18926/AMO/54001
フルテキストURL 70_1_31.pdf
著者 Hanada, Takae| Kanamitsu, Kiichiro| Chayama, Kosuke| Miyamura, Takako| Kanazawa, Yui| Muraoka, Michiko| Washio, Kana| Imada, Masahide| Kageyama, Misao| Takeuchi, Akihito| Tamai, Kei| Oda, Megumi| Shimada, Akira|
抄録 The treatment of patients with congenital leukemia is difficult and often results in a poor prognosis. We present here the case of a female child with congenital acute myeloid leukemia (AML) with t(8 ; 16) (p11 ; p13) who received chemotherapy and survived for more than 10 years without relapse. A novel MOZ-CBP chimera was found in her diagnostic sample. Although adult AML patients with MOZ-CBP have mainly been reported as having therapy-related AML and showed poor prognoses, the present case supports the idea that AML with MOZ-CBP in the pediatric population might show better prognoses.
キーワード congenital leukemia AML t(8 ; 16)(p11 ; p13) MOZ-CBP
Amo Type Original Article
発行日 2016-02
出版物タイトル Acta Medica Okayama
70巻
1号
出版者 Okayama University Medical School
開始ページ 31
終了ページ 35
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
著作権者 CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 26899607
Web of Sience KeyUT 000371288700004